Ignite Creation Date:
2024-05-06 @ 1:06 AM
Last Modification Date:
2024-10-26 @ 10:58 AM
Study NCT ID:
NCT01723306
Status:
SUSPENDED
Last Update Posted:
2016-06-14
First Post:
2012-11-01
Brief Title:
Phase IIPilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas
Sponsor:
Organization:
Roger Williams Medical Center
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
48
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: